Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03868670 · ClinicalTrials.gov registry record · NA

Responsive Neurostimulation For Loss Of Control Eating

A NA study of Obesity, Morbid and Loss-of-control Eating, sponsored by University of Pennsylvania.

Active
Registry status
NA
Development phase
6
Enrollment target
2
Study locations

NCT03868670 is a NA study of Obesity, Morbid and Loss-of-control Eating that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 6 participants, below the 103-participant average among 19 other Obesity, Morbid trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03868670, a NA study of Obesity, Morbid and Loss-of-control Eating, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
6 participants
Enrollment target
2
Study locations

Study Summary

The primary objective of this trial is to assess device function and safety, with secondary objectives including the feasibility.

Interventions

  • DEVICE responsive neurostimulation

Study Locations (2)

California

  • Stanford University - Stanford

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2019-04-10
Est. Completion 2028-01-01
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT03868670

The ClinicalTrials.gov registry entry for NCT03868670 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 103-participant average among 19 other Obesity, Morbid trials with a reported enrollment target (94% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity, Morbid appearing as the primary indexed condition, and to 1 intervention - of which responsive neurostimulation is the first listed.

NCT03868670 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03868670 about?

NCT03868670 is a clinical study titled "Responsive Neurostimulation For Loss Of Control Eating". The primary objective of this trial is to assess device function and safety, with secondary objectives including the feasibility.

What is the current status of trial NCT03868670?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2019-04-10. Estimated completion is 2028-01-01.

What conditions does trial NCT03868670 study?

This clinical trial studies the following conditions: Obesity, Morbid, Loss-of-control Eating.

What interventions are being tested in trial NCT03868670?

The interventions under investigation include: responsive neurostimulation (DEVICE).

Who is sponsoring clinical trial NCT03868670?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03868670 being conducted?

This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity, Morbid

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.